0.00Open2.57Pre Close0 Volume2 Open Interest81.00Strike Price0.00Turnover52.96%IV1.11%PremiumDec 6, 2024Expiry Date1.69Intrinsic Value100Multiplier3DDays to Expiry0.88Extrinsic Value100Contract SizeAmericanOptions Type-0.6511Delta0.0931Gamma30.86Leverage Ratio-0.2346Theta-0.0044Rho-20.09Eff Leverage0.0278Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet